We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Indivior has reached an agreement to pay $600m to settle US claims that the company had run an illegal scheme to increase prescriptions of its opioid addiction treatment, Suboxone.